Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)

  • Matthew J Maurer (Lecturer)
  • Lasse H. Jakobsen (Other)
  • Norbert Schmitz (Other)
  • Umar Farooq (Other)
  • Christopher R. Flowers Flowers (Other)
  • Peter de Nully Brown (Other)
  • Frederiksen, H. (Guest lecturer)
  • Viola Poeschel (Other)
  • Grzegorz S. Nowakowski (Other)
  • John Francis Seymour (Other)
  • Francesco Francesco Merl Francesco Merli (Other)
  • Corinne Haioun (Other)
  • Herve Ghesquieres (Other)
  • Marita Ziepert (Other)
  • Hervé Tilly (Other)
  • Gilles Andre Salles (Other)
  • Qiang Shi (Other)
  • Tarec Christoffer El-Galaly (Other)
  • Carrie A Thompson (Other)
  • Thomas M. Habermann (Other)
  • David Cunningham (Guest lecturer)
  • Judit M Jørgensen (Other)

Activity: Talks and presentationsConference presentations

Period8. Dec 2019
Event titleAmerican Society of Hematology: 61st Annual Meeting (ASH)
Event typeConference
LocationOrlando, United States